Bank of America’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-459
Closed -$1.68K 6107
2025
Q4
$1.68K Sell
459
-6,663
-94% -$19K ﹤0.01% 6423
2025
Q3
$26.3K Buy
7,122
+6,426
+923% +$16.2K ﹤0.01% 7011
2025
Q2
$1.29K Buy
696
+37
+6% +$64 ﹤0.01% 7487
2025
Q1
$1.03K Buy
659
+53
+9% +$93 ﹤0.01% 7417
2024
Q4
$1.23K Sell
606
-303
-33% -$549 ﹤0.01% 7257
2024
Q3
$1.31K Buy
909
+27
+3% +$51 ﹤0.01% 7196
2024
Q2
$1.51K Buy
882
+111
+14% +$201 ﹤0.01% 7179
2024
Q1
$1.54K Sell
771
-14
-2% -$28 ﹤0.01% 7156
2023
Q4
$2.36K Sell
785
-189
-19% -$500 ﹤0.01% 7115
2023
Q3
$4.24K Buy
974
+33
+4% +$226 ﹤0.01% 7029
2023
Q2
$7.76K Sell
941
-114
-11% -$1.13K ﹤0.01% 6920
2023
Q1
$13K Sell
1,055
-1,423
-57% -$16.9K ﹤0.01% 6869
2022
Q4
$24.3K Buy
2,478
+427
+21% +$4.73K ﹤0.01% 6678
2022
Q3
$26K Buy
2,051
+1,529
+293% +$22.9K ﹤0.01% 6935
2022
Q2
$7K Sell
522
-165
-24% -$2.44K ﹤0.01% 7501
2022
Q1
$14K Sell
687
-7,990
-92% -$219K ﹤0.01% 7641
2021
Q4
$326K Buy
8,677
+1,453
+20% +$64.8K ﹤0.01% 6188
2021
Q3
$349K Buy
7,224
+135
+2% +$6.59K ﹤0.01% 5903
2021
Q2
$379K Buy
7,089
+3,582
+102% +$216K ﹤0.01% 5637
2021
Q1
$185K Buy
3,507
+2,023
+136% +$114K ﹤0.01% 6092
2020
Q4
$70K Buy
1,484
+80
+6% +$3.46K ﹤0.01% 6159
2020
Q3
$85K Sell
1,404
-1,688
-55% -$86K ﹤0.01% 5779
2020
Q2
$124K Sell
3,092
-533
-15% -$19.8K ﹤0.01% 5562
2020
Q1
$103K Buy
3,625
+3,078
+563% +$102K ﹤0.01% 5514
2019
Q4
$21K Hold
547
﹤0.01% 6494
2019
Q3
$12K Sell
547
-1,819
-77% -$42.8K ﹤0.01% 6683
2019
Q2
$54K Buy
2,366
+1,773
+299% +$45.6K ﹤0.01% 6273
2019
Q1
$15K Sell
593
-530
-47% -$13.9K ﹤0.01% 6557
2018
Q4
$15K Buy
1,123
+769
+217% +$12.8K ﹤0.01% 6550
2018
Q3
$8K Sell
354
-216
-38% -$6.91K ﹤0.01% 6723
2018
Q2
$25K Sell
570
-157
-22% -$8.84K ﹤0.01% 6431
2018
Q1
$49K Sell
727
-94
-11% -$5.95K ﹤0.01% 6047
2017
Q4
$49K Buy
821
+107
+15% +$6.3K ﹤0.01% 6078
2017
Q3
$47K Buy
714
+270
+61% +$18.2K ﹤0.01% 5970
2017
Q2
$32K Sell
444
-19
-4% -$1.12K ﹤0.01% 6054
2017
Q1
$25K Buy
463
+91
+24% +$4.07K ﹤0.01% 6224
2016
Q4
$15K Buy
372
+137
+58% +$5.12K ﹤0.01% 6444
2016
Q3
$11K Sell
235
-343
-59% -$14.6K ﹤0.01% 6350
2016
Q2
$23K Buy
578
+491
+564% +$22.9K ﹤0.01% 6179
2016
Q1
$4K Hold
87
﹤0.01% 6630
2015
Q4
$4K Sell
87
-200
-70% -$8.38K ﹤0.01% 6938
2015
Q3
$11K Buy
287
+147
+105% +$6.87K ﹤0.01% 6525
2015
Q2
$7K Sell
140
-1,274
-90% -$65.4K ﹤0.01% 6704
2015
Q1
$82K Sell
1,414
-5,439
-79% -$227K ﹤0.01% 5414
2014
Q4
$251K Sell
6,853
-54
-0.8% -$1.59K ﹤0.01% 5189
2014
Q3
$218K Sell
6,907
-7,082
-51% -$188K ﹤0.01% 5314
2014
Q2
$361K Buy
13,989
+6,735
+93% +$178K ﹤0.01% 4942
2014
Q1
$215K Sell
7,254
-648
-8% -$25.3K ﹤0.01% 5380
2013
Q4
$312K Sell
7,902
-3,336
-30% -$129K ﹤0.01% 5188
2013
Q3
$1.18M Buy
11,238
+6,599
+142% +$809K ﹤0.01% 3779
2013
Q2
$598K Buy
+4,639
New +$684K ﹤0.01% 4577

Other funds holding FBIO

Bank of America's FBIO Position: Q1 2026 in Review

Bank of America sold out of Fortress Biotech (FBIO) in Q1 2026, closing a stake of 459 shares — an estimated $1.68K sold.

Bank of America first reported a position in FBIO in Q2 2013 and held it in 51 quarters. The position peaked at $1.18M in Q3 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Bank of America reported no remaining Fortress Biotech position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 459 Fortress Biotech shares in Q1 2026, an estimated $1.68K.
  • Bank of America first reported a position in Fortress Biotech in Q2 2013 and held it in 51 quarters.
  • Bank of America's Fortress Biotech position peaked at $1.18M in Q3 2013.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.